Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

NEUROPACE, INC.

(NPCE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NEUROPACE, INC.
11/11Wells Fargo Adjusts Price Target on NeuroPace to $20 From $28, Reiterates Overweight Ra..
MT
11/10NeuroPace Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/10Earnings Flash (NPCE) NEUROPACE Reports Q3 Revenue $10.3M, vs. Street Est of $10.8M
MT
11/10NeuroPace Reports Third Quarter 2021 Financial Results
AQ
11/10Neuropace, Inc. Provides Revenue Guidance for the Full Year 2021
CI
11/10NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of itsáRNS System fo..
AQ
11/10NeuroPace, Inc. Receives IDE Approval to Initiate Nautilus Pivotal Study of Its RNS Sys..
CI
10/20NEUROPACE : to Report Third Quarter 2021 Financial Results onáNovember 10, 2021
GL
10/20NeuroPace to Report Third Quarter 2021 Financial Results onáNovember 10, 2021
GL
10/19NEUROPACE : Announces Addition of Lisa Andrade to the Board
AQ
10/19Neuropace, Inc. Announces Addition of Lisa Andrade to the Board
CI
10/19Certain Stock Options of NeuroPace, Inc. are subject to a Lock-Up Agreement Ending on 1..
CI
10/19Certain Common Stock of NeuroPace, Inc. are subject to a Lock-Up Agreement Ending on 19..
CI
09/20NEUROPACE, INC.(NASDAQGM : NPCE) added to S&P Global BMI Index
CI
08/23NEUROPACE : to Participate in Upcoming Conferences
AQ
More most relevant news
All news about NEUROPACE, INC.
11/11Wells Fargo Adjusts Price Target on NeuroPace to $20 From $28, Reiterates Overweight Ra..
MT
11/10NEUROPACE INC Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10NeuroPace Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/10Earnings Flash (NPCE) NEUROPACE Reports Q3 Revenue $10.3M, vs. Street Est of $10.8M
MT
11/10NeuroPace Reports Third Quarter 2021 Financial Results
AQ
11/10Neuropace, Inc. Provides Revenue Guidance for the Full Year 2021
CI
11/10NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of itsáRNS System fo..
AQ
11/10NeuroPace, Inc. Receives IDE Approval to Initiate Nautilus Pivotal Study of Its RNS Sys..
CI
10/20NEUROPACE : to Report Third Quarter 2021 Financial Results onáNovember 10, 2021
GL
10/20NeuroPace to Report Third Quarter 2021 Financial Results onáNovember 10, 2021
GL
More news
News in other languages on NEUROPACE, INC.
11/10Earnings Flash (NPCE) NEUROPACE annonce un chiffre d'affaires de 10,3 millions de dolla..
11/10Neuropace, Inc. fournit des prévisions de revenus pour l'ensemble de l'année 2021
08/12NeuroPace réduit fortement sa perte au deuxième trimestre et améliore ses revenus
08/12Earnings Flash (NPCE) NEUROPACE annonce un chiffre d'affaires de 12,6 millions de dolla..
08/12NeuroPace, Inc. réitère ses prévisions financières pour l'ensemble de l'année 2021
06/30NeuroPace obtient une subvention de 9,3 millions de dollars du NIH pour évaluer la tech..
06/03NeuroPace réduit sa perte au premier trimestre et améliore ses revenus
06/03NeuroPace, Inc. donne ses prévisions de chiffre d'affaires pour le deuxième trimestre e..
06/03Earnings Flash (NPCE) NEUROPACE annonce un chiffre d'affaires de 11,2 millions de dolla..
04/22NeuroPace fait un bond de 38 % à son entrée au Nasdaq
More news
Analyst Recommendations on NEUROPACE, INC.
11/11Wells Fargo Adjusts Price Target on NeuroPace to $20 From $28, Reiterates Overweight Ra..
MT
08/18NEUROPACE : Baird Starts NeuroPace at Outperform With $26 Price Target
MT
05/17NEUROPACE : Morgan Stanley Initiates NeuroPace at Overweight With $26 Price Target
MT
05/17NEUROPACE : SVB Leerink Initiates NeuroPace at Outperform Rating With $25 Price Target
MT
05/17NEUROPACE : JPMorgan Starts NeuroPace at Overweight With $27 Price Target
MT
More recommendations
Press releases
11/10NEUROPACE INC Management's Discussion and Analysis of Financial Condition and Results ..
AQ
11/10NeuroPace Reports Third Quarter 2021 Financial Results - Form 8-K
PU
11/10NeuroPace Reports Third Quarter 2021 Financial Results
AQ
11/10NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of itsáRNS System fo..
AQ
10/20NEUROPACE : to Report Third Quarter 2021 Financial Results onáNovember 10, 2021
GL
More press releases
Upcoming event on NEUROPACE, INC.
08/11/22